Advertisement
The Haridwar-based company is struggling to meet the demand as it is able to supply only around one lakh packs, Ramdev said on Wednesday, August 5.
“Today we have a demand of 10 lakh packs of Coronil daily and we are able to supply only one lakh,” he claimed.
Stressing that Patanjali Ayurved had priced it only at Rs 500, Ramdev said, “Had we put a higher price of even Rs 5,000, in this Covid-19 times, we could have easily earned up to Rs 5,000 crore from this. But we have not done so.”
Related Articles
Advertisement
Earlier in June, Ramdev had claimed that Coronil can cure Covid-19 patients. However, the AYUSH Ministry immediately put restrictions on Patanjali overselling it. Later, the Union ministry confirmed that Patanjali can sell the product only as an immunity booster but not as a cure for Covid-19. The Madras High Court had restrained Patanjali from using Coronil trademark till July 30, over a petition filed a Chennai-based company.
Ramdev suggested industry leaders to work with honesty to build a brand on which the people have trust and it needs a long term approach.
“To maintain that trust, you have to work honestly with dedication,” he said.
He also asked people to have patience during the pandemic in order to come out of the health crisis.
According to him, Patanjali has become a brand, which is a combined result of efforts, respect for traditional knowledge, and hard work.
“Now Patanjali has become a big brand…. the success mantra of Patanjali is – knowledge, faith, respect and efforts only,” he said.
“Several companies mocked on us with derision saying that Patanjali has faith but not science,” he added.
“Today we have over 500 scientists working for us. We could not have done this if we had no knowledge about it,” he said.
According to him though he believes in guru–shishya tradition, religion, and culture, he also believes in scientific temperament.
“We have made our cow ghee a Rs 1,300-1,400 crore annual brand,” he said adding that several companies, operating in the segment, failed to create such a big brand in the segment.
Patanjali group has an estimated turnover of around 10,500 crore. It had acquired debt-ridden Ruchi Soya in a corporate insolvency resolution process for around Rs 4,350 crore after competing with Adani Group.
Ayurved had reported a turnover of Rs 8,329 crore in FY2018-19. However, the total turnover of the group was higher as Patanjali Ayurved consists of its FMCG business and Ayurvedic medicines.
Businesses like biscuits, noodles, dairy business, solar panels, and apparels are not part of Patanjali Ayurved Ltd.